Home › NCT04623424

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission

Who can join

Ages 18 to 80 · All sexes

Inclusion Criteria:

* Patients aged 18-80 years
* patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure

About the study

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

What is being tested

• intestinal microbiota (diagnostic test)

Sponsor: Henry Ford Health System · Participants: 255 · Started: Nov 3, 2020

Contact the study team

• shatha farhan, MD · Phone: 313 916 5002

Official record on ClinicalTrials.gov — NCT04623424

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.